"If you're an observer of medical devices, you have a smile on your face today."

— Larry Haimovitch, president of Haimovitch Medical Technology Consultants, on the news that Abbott acquired Evalve for roughly $410 million, "Abbott to pump up portfolio by paying up to $410M for Evalve."